The American Society for Cell Biology (ASCB) Council has named its 2020 cohort of Fellows, ASCB members selected for their lifetime achievements in advancing cell biology. McGowan Institute for Regenerative Medicine affiliated faculty member Ora Weisz, PhD, was one of 18 members who were chosen for their outstanding contributions to the field of cell biology and to the community of cell biologists through their service to the Society.
Dr. Weisz is a Professor in the Departments of Medicine (Renal-Electrolyte Division), Cell Biology, and Clinical and Translational Science at the University of Pittsburgh. She is also the Vice Chair of Faculty Development in the Department of Medicine, the Associate Dean for Faculty Development in Pitt’s School of Medicine, and Assistant Vice Chancellor for Faculty Excellence, Health Sciences.
Dr. Weisz’s research interest focuses broadly on understanding how membrane traffic in proximal tubule cells responds to physiologic cues to maintain kidney function. Her team is unraveling the mechanisms by which proximal tubule cells in the kidney alter their endocytic and ion transport capacity in response to changes in tubular flow and the accompanying fluid shear stress. These studies have direct implications for the understanding and treatment of genetic and other disorders that result in tubular proteinuria and eventually lead to kidney failure, including Lowe syndrome, Dent disease, and sickle cell disease.
The ASCB Fellows program is committed to recognizing the breadth and diversity of the Society’s membership. Toward this end, Fellows are nominated by their peers or through self-nomination, followed by evaluation and selection by a Fellows Nomination Review Committee. The list of selected Fellow nominees is reviewed and approved by the ASCB Council. The ASCB Fellows will be formally recognized at Cell Bio Virtual 2020–An Online ASCB|EMBO Meeting in December 2020.
Congratulations, Dr. Weisz!